Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome

Cytokine

Volumn 40, Issue 2, 2007, Pages 82-88

  Tranquilli, Andrea L ^a   Landi, Beatrice ^a   Corradetti, Alessandra ^a   Giannubilo, Stefano R ^a   Sartini, Davide ^a   Pozzi, Valentina ^a   Emanuelli, Monica ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Cytokines; HELLP syndrome; Immune response; Macroarray

Indexed keywords

CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 6 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HELLP SYNDROME; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; NORMAL HUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ADULT; CESAREAN SECTION; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION PROFILING; HELLP SYNDROME; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PREGNANCY;

EID: 36549044967     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.08.010     Document Type: Article

References (32)

1. Murphy D.J., and Stirrat G.M. Mortality and morbidity associated with early-onset pre-eclampsia. Hypertens Pregnancy 19 (2000) 221-231
2. Simic M., Tasic M., Stojiljkovic G., Draskovic D., and Vukovic R. HELLP syndrome as a cause of unexpected rapid maternal death-a case report and review of the literature. Int J Legal Med 119 (2005) 103-106
3. Buckingham K.L., Stone P.R., Smith J.F., and Chamley L.W. An antiphospholipid antibody in serum and follicular fluid is there a correlation with IVF implantation failure?. Hum Reprod 21 (2006) 728-734
4. Wegmann T.G., Lin H., Guilbert L., and Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today 14 (1993) 353-356
5. Mellembakken J.R., Aukrust P., Hestdal K., Ueland T., Abyholm T., and Videm V. Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension 38 (2001) 394-398
6. Litos M., Sarris I., Bewley S., Seed P., Okpala I., and Oteng-Ntim E. White blood cell count as a predictor of the severity of sickle cell disease during pregnancy. Eur J Obstet Gynecol Reprod Biol 133 (2007) 169-172
7. Sacks G.P., Redman C.W., and Sargent I.L. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 13 (2003) 490-497
8. Miwa N., Hayakawa S., Miyazaki S., Myojo S., Sasaki Y., Sakai M., et al. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod 11 (2005) 865-870
9. Benyo D.F., Smarason A., Redman C.W., Sims C., and Conrad K.P. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 86 (2001) 2505-2512
10. Pang Z.J., and Xing F.Q. Comparative study on the expression of cytokine-receptor genes in normal and preeclamptic human placentas using DNA microarrays. J Perinat Med 31 (2003) 153-162
11. Sargent I.L., Borzychowski A.M., and Redman C.W. NK cells and human pregnancy-an inflammatory view. Trends Immunol 27 (2006) 399-404
12. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes and low platelet count. Obstet Gynecol 103 (2004) 981-991
13. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. In: ACOG practice bulletin no. 12. Washington, DC: American College of Obstetricians and Gynecologists; 2000.
14. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174 (1991) 915-924
15. Austgulen R., Lien E., Liabakk N.B., Jacobsen G., and Arntzen K.J. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 57 (1994) 149-155
16. Huang S.J., Schatz F., Masch R., Rahman M., Buchwalder L., Niven-Fairchild T., et al. Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells. J Reprod Immunol 72 (2006) 60-73
17. Heyborne K.D., McGregor J.A., Henry G., Witkin S.S., and Abrams J.S. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 171 (1994) 55-59
18. Meisser A., Cameo P., Islami D., Campana A., and Bischof P. Effects of interleukin-6 (IL-6) on cytotrophoblastic cells. Mol Hum Reprod 5 (1999) 1055-1058
19. Roth I., and Fisher S.J. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 205 (1999) 194-204
20. Kauma S.W., Wang Y., and Walsh S.W. Preeclampsia is associated with decreased placental interleukin-6 production. J Soc Gynecol Investig 2 (1995) 614-617
21. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16 (1998) 249-284
22. Pepper M.S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8 (1997) 21-43
23. Caniggia I., Grisaru-Gravnosky S., Kuliszewsky M., Post M., and Lye S.J. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 103 (1999) 1641-1650
24. Taipale J., Miyazono K., Heldin C.H., and Keski-Oja J. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 124 (1994) 171-181
25. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
26. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
27. Baggiolini M., Dewald B., and Moser B. Human chemokines: an update. Annu Rev Immunol 15 (1997) 675-705
28. Strieter R.M., Polverini P.J., and Kunkel S.L. The functional role of the ELR motif in CXC chemokine mediated angiogenesis. J Biol Chem 270 (1995) 27348-27357
29. Little F.F., de Bie J., van Oosterhout A., Kornfeld H., Center D.M., and Cruikshank W.W. Immunomodulatory effect of interleukin-16 on allergic airway inflammation. Chest 123 (2003) 431-432
30. El Bassam S., Pinsonneault S., Kornfeld H., Ren F., Menezes J., and Laberge S. Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells. Immunology 117 (2006) 89-96
31. Pitzalis C., Pipitone N., and Perretti M. Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann NY Acad Sci 966 (2002) 108-118
32. Barnes P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94 (1998) 557-572